Red Light Holland Corp. TRUFF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

34/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Red Light Holland Corp. (TRUFF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 32/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

34/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

36/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — TRUFF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio1.66

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.01

Book Value / Share$0.00

Revenue / Share$0.01

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$0.07	$378.4K	$510.86K	135%
2017	$0.01	$187.5K	$145.31K	77.5%
2018	$0.00	$40.82K	$-309.38K	-757.9%
2019	$0.00	$10.84K	$-180.04K	-1660.3%
2020	$-0.38	$0.00	$-325.17K	-
2021	$0.00	$110.96K	$-325.17K	-293.1%
2022	$0.00	$110.96K	$-1.64M	-1482.4%
2023	$-0.01	$3.95M	$-5.4M	-136.7%
2024	$-0.02	$4.75M	$-7.63M	-160.5%
2025	$-0.01	$4.94M	$-4.04M	-81.8%